TY - JOUR T1 - Assessing the Value of New Antimicrobials: Evaluations of Cefiderocol and Ceftazidime-Avibactam to Inform Delinked Payments by the NHS in England JO - Applied Health Economics and Health Policy UR - http://dx.doi.org/10.1007/s40258-024-00924-x PY - 2024/11/30 AU - Woods B AU - Kearns B AU - Schmitt L AU - Jankovic D AU - Rothery C AU - Harnan S AU - Hamilton J AU - Scope A AU - Ren S AU - Bojke L AU - Wilcox M et al ED - DO - DOI: 10.1007/s40258-024-00924-x PB - Springer Science and Business Media LLC SP - 1 EP - 13 Y2 - 2025/07/27 ER -